5.270USD-4.01%Mkt Cap: 324.50M $P/E: —2d ago
TriSalus Life Sciences, Inc. engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat live…
Industry Peers
Medical Devices$203.17BUSDP/E 37.7
$126.37BUSDP/E 34.2
$119.49BUSDP/E 25.0
$73.00BUSDP/E 20.4
$48.43BUSDP/E 19.9
$51.70BUSDP/E 53.4
$34.85BUSDP/E 36.5
$34.04BUSDP/E 17.2
$25.08BUSDP/E 20.7
$26.80BUSDP/E 20.8
$23.20BUSDP/E 29.1
$19.26BUSDP/E 24.5
$12.81BUSDP/E 79.7
$12.25BUSDP/E 19.9
$11.48BUSDP/E 19.8
$11.67BUSDP/E 22.2
$10.91BUSD
$10.01BUSDP/E 17.1
$10.28BUSDP/E 27.5
$10.17BUSDP/E 46.3
Key Statistics
Company
Market Cap324.50M $
Enterprise Value310.17M $
Revenue (TTM)45.08M $
Gross Profit38.19M $
Net Income (TTM)-39.23M $
Revenue/Share0.9010 USD
Last Price5.270 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees102
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-20.92
PEG—
EV/EBITDA-10.36
EV/Revenue6.88
P/S7.14
P/B48.88
EPS (TTM)-1.27
EPS (Forward)-0.25
52W Range
2.20053% of range7.950
52W High7.950 USD
52W Low2.200 USD
Profitability
Gross Margin84.57%
Oper. Margin-86.03%
EBITDA Margin-66.44%
Profit Margin-86.88%
ROE115.85%
ROA-111.03%
Growth
Revenue Growth1.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.01M $
CapEx (TTM)918.00K $
FCF Margin-24.13%
FCF Yield-3.35%
Net Debt-11.86M $
Net Debt/EBITDA0.40
Balance Sheet
Debt/Equity-1.02
Current Ratio5.35
Quick Ratio4.72
Book Value/Sh0.1070 USD
Cash/Share0.7520 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.00 USD
Upside (mean)+89.8%
Target Range7.000 USD – 14.00 USD
$7.000+89.8% to mean$14.00
# Analysts4
Ownership
Shares Out.61.57M
Float49.50M
Insiders33.96%
Institutions35.71%
Short Interest
Short Ratio17.2d
Short % Float8.10%
Short % Out.6.14%
Shares Short3.77M
Short (prev mo.)3.08M
Technical
SMA 504.515 (+16.7%)
SMA 2004.805 (+9.7%)
Beta0.43
S&P 52W Chg18.16%
Avg Vol (30d)210.73K
Avg Vol (10d)222.75K
Technical Indicators
RSI (14)58.6
MACD0.3181
MACD Signal0.3106
MACD Hist.+0.0075
BB Upper6.055 USD
BB Middle4.958 USD
BB Lower3.862 USD
BB Width44.24%
ATR (14)0.3420 USD
Vol Ratio (20d)0.45x